JP2024515555A5 - - Google Patents

Info

Publication number
JP2024515555A5
JP2024515555A5 JP2023561628A JP2023561628A JP2024515555A5 JP 2024515555 A5 JP2024515555 A5 JP 2024515555A5 JP 2023561628 A JP2023561628 A JP 2023561628A JP 2023561628 A JP2023561628 A JP 2023561628A JP 2024515555 A5 JP2024515555 A5 JP 2024515555A5
Authority
JP
Japan
Application number
JP2023561628A
Other languages
Japanese (ja)
Other versions
JPWO2022217231A5 (https=
JP2024515555A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/071562 external-priority patent/WO2022217231A1/en
Publication of JP2024515555A publication Critical patent/JP2024515555A/ja
Publication of JPWO2022217231A5 publication Critical patent/JPWO2022217231A5/ja
Publication of JP2024515555A5 publication Critical patent/JP2024515555A5/ja
Pending legal-status Critical Current

Links

JP2023561628A 2021-04-06 2022-04-05 L-アスパラギナーゼの製剤 Pending JP2024515555A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163171429P 2021-04-06 2021-04-06
US63/171,429 2021-04-06
PCT/US2022/071562 WO2022217231A1 (en) 2021-04-06 2022-04-05 Formulations of l-asparaginase

Publications (3)

Publication Number Publication Date
JP2024515555A JP2024515555A (ja) 2024-04-10
JPWO2022217231A5 JPWO2022217231A5 (https=) 2025-04-14
JP2024515555A5 true JP2024515555A5 (https=) 2025-04-14

Family

ID=81748398

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023561628A Pending JP2024515555A (ja) 2021-04-06 2022-04-05 L-アスパラギナーゼの製剤

Country Status (12)

Country Link
EP (1) EP4319818A1 (https=)
JP (1) JP2024515555A (https=)
KR (1) KR20230165799A (https=)
CN (1) CN117377494A (https=)
AR (1) AR125301A1 (https=)
AU (1) AU2022256071A1 (https=)
BR (1) BR112023019862A2 (https=)
CA (1) CA3213726A1 (https=)
CL (1) CL2023002983A1 (https=)
CO (1) CO2023014093A2 (https=)
MX (1) MX2023011693A (https=)
WO (1) WO2022217231A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022211829A1 (en) 2021-03-30 2022-10-06 Jazz Pharmaceuticals Ireland Ltd. Dosing of recombinant l-asparaginase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7985548B2 (en) 2006-03-03 2011-07-26 The United States Of America As Represented By The Department Of Health And Human Services Materials and methods directed to asparagine synthetase and asparaginase therapies
KR102783452B1 (ko) * 2016-06-01 2025-03-19 세르비에 아이피 유케이 리미티드 폴리알킬렌 옥시드-아스파라기나제의 제형, 및 그의 제조 및 사용 방법
JP2021505661A (ja) * 2017-11-30 2021-02-18 ジャズ ファーマシューティカルズ アイルランド リミテッド アスパラギナーゼを用いた治療法
JP2022553399A (ja) * 2019-10-25 2022-12-22 ジャズ ファーマシューティカルズ アイルランド リミテッド 組換えl-アスパラギナーゼ

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
JP2024515555A5 (https=)
CL2026000295A1 (es) Membranas adsorbentes a base de salicilaldoxima de imidazol de zinc para capturar iones metálicos.
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
CN307044421S (https=)
CN303392045S8 (https=)
CN307045519S (https=)
CN307044903S (https=)
CN307045547S (https=)
CN307044765S (https=)
CN307044758S (https=)
CN307046281S (https=)
CN307046448S (https=)
CN307044367S (https=)